AlzProtect
Lille, FR · 1 known investors
Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.
Founders & leadership
PV
Philippe VerwaerdePresident & Chief Science Officer
Investors · 1
Frequently asked questions
- What does AlzProtect do?
- Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.
- Who are AlzProtect's investors?
- AlzProtect's investors include Xerys.
- Where is AlzProtect headquartered?
- AlzProtect is headquartered in Lille, FR.